Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Expert Opinion on Drug Safety
|
September 29, 2025
Auditory system adverse events with sacubitril/valsartan: an active-comparator restricted disproportionality analysis using the FDA adverse event reporting system database
Atefeh Jafari, Niaz Chalabianloo, Flory T Muanda
Sensors (Basel, Switzerland)
|
April 21, 2019
Continuous Stress Detection Using Wearable Sensors in Real Life: Algorithmic Programming Contest Case Study
Yekta Said Can, Niaz Chalabianloo, Deniz Ekiz, et al.
Journal of Psychopharmacology (Oxford, England)
|
July 24, 2025
β-blockers and risk of neuropsychiatric adverse events: An active-comparator restricted disproportionality on the FAERS
Lujain Ez Eddin, Mohammad Ali Omrani, Niaz Chalabianloo, et al.
Sensors (Basel, Switzerland)
|
February 9, 2020
How Laboratory Experiments Can Be Exploited forMonitoring Stress in the Wild: A Bridge BetweenLaboratory and Daily Life
Yekta Said Can, Dilara Gokay, Dilruba Reyyan Kılıç, et al.
Plos One
|
September 25, 2025
Enhancing adverse drug reaction data quality in Canada: A high-precision pipeline for medication name standardization and enrichment
Niaz Chalabianloo, Sheikh S Abdullah, Mohammad Ali Omrani, et al.
The Journal of Antimicrobial Chemotherapy
|
July 15, 2025
Trimethoprim/sulfamethoxazole and risk of haemophagocytic lymphohistiocytosis (HLH): a literature review and disproportionality analysis using individual case safety reports from FAERS
Rinko Lau, Hasti Sadeghi, Fatemeh Ahmadi, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 27, 2025
Fluoroquinolones and risk of nightmares: A literature review and disproportionality analysis using individual case safety reports from Food and Drug Administration Adverse Event Reporting System database
Mohammad Ali Omrani, Christian T Tsobo, Niaz Chalabianloo, et al.
The Annals of Pharmacotherapy
|
February 27, 2025
Severe Acute Respiratory Failure Associated With Trimethoprim/Sulfamethoxazole Among Adolescent and Young Adults: An Active Comparator-Restricted Disproportionality Analysis From the FDA Adverse Event Reporting System (FAERS) Database
Fatemeh Ahmadi, Niaz Chalabianloo, Eric McArthur, et al.
Healthcare (Basel, Switzerland)
|
April 23, 2020
How to Relax in Stressful Situations: A Smart Stress Reduction System
Yekta Said Can, Heather Iles-Smith, Niaz Chalabianloo, et al.
British Journal of Clinical Pharmacology
|
December 5, 2025
Machine learning methods for predicting adverse drug events: A systematic review
Niaz Chalabianloo, Fatemeh Ahmadi, Mohammad Ali Omrani, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Expert Opinion on Drug Safety
|
September 29, 2025
Auditory system adverse events with sacubitril/valsartan: an active-comparator restricted disproportionality analysis using the FDA adverse event reporting system database
Atefeh Jafari, Niaz Chalabianloo, Flory T Muanda
Sensors (Basel, Switzerland)
|
April 21, 2019
Continuous Stress Detection Using Wearable Sensors in Real Life: Algorithmic Programming Contest Case Study
Yekta Said Can, Niaz Chalabianloo, Deniz Ekiz, et al.
Journal of Psychopharmacology (Oxford, England)
|
July 24, 2025
β-blockers and risk of neuropsychiatric adverse events: An active-comparator restricted disproportionality on the FAERS
Lujain Ez Eddin, Mohammad Ali Omrani, Niaz Chalabianloo, et al.
Sensors (Basel, Switzerland)
|
February 9, 2020
How Laboratory Experiments Can Be Exploited forMonitoring Stress in the Wild: A Bridge BetweenLaboratory and Daily Life
Yekta Said Can, Dilara Gokay, Dilruba Reyyan Kılıç, et al.
Plos One
|
September 25, 2025
Enhancing adverse drug reaction data quality in Canada: A high-precision pipeline for medication name standardization and enrichment
Niaz Chalabianloo, Sheikh S Abdullah, Mohammad Ali Omrani, et al.
The Journal of Antimicrobial Chemotherapy
|
July 15, 2025
Trimethoprim/sulfamethoxazole and risk of haemophagocytic lymphohistiocytosis (HLH): a literature review and disproportionality analysis using individual case safety reports from FAERS
Rinko Lau, Hasti Sadeghi, Fatemeh Ahmadi, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 27, 2025
Fluoroquinolones and risk of nightmares: A literature review and disproportionality analysis using individual case safety reports from Food and Drug Administration Adverse Event Reporting System database
Mohammad Ali Omrani, Christian T Tsobo, Niaz Chalabianloo, et al.
The Annals of Pharmacotherapy
|
February 27, 2025
Severe Acute Respiratory Failure Associated With Trimethoprim/Sulfamethoxazole Among Adolescent and Young Adults: An Active Comparator-Restricted Disproportionality Analysis From the FDA Adverse Event Reporting System (FAERS) Database
Fatemeh Ahmadi, Niaz Chalabianloo, Eric McArthur, et al.
Healthcare (Basel, Switzerland)
|
April 23, 2020
How to Relax in Stressful Situations: A Smart Stress Reduction System
Yekta Said Can, Heather Iles-Smith, Niaz Chalabianloo, et al.
British Journal of Clinical Pharmacology
|
December 5, 2025
Machine learning methods for predicting adverse drug events: A systematic review
Niaz Chalabianloo, Fatemeh Ahmadi, Mohammad Ali Omrani, et al.
Page
of 2